Form S-3 ADC Therapeutics SA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
ADC Therapeutics SA (ADCT) Files $300M Mixed Shelf
August 6, 2024 4:29 PM EDTADC Therapeutics SA (NYSE: ADCT) has filed $300,000,000 mixed shelf of:
Common Shares
Debt Securities
Warrants
Subscription Rights
Purchase Contracts
Units



